159 related articles for article (PubMed ID: 16897188)
21. Epigenetic silencing of tumor suppressor miR-3151 contributes to Chinese chronic lymphocytic leukemia by constitutive activation of MADD/ERK and PIK3R2/AKT signaling pathways.
Wang LQ; Wong KY; Rosèn A; Chim CS
Oncotarget; 2015 Dec; 6(42):44422-36. PubMed ID: 26517243
[TBL] [Abstract][Full Text] [Related]
22. Epigenetic inactivation of mir-34b/c in addition to mir-34a and DAPK1 in chronic lymphocytic leukemia.
Wang LQ; Kwong YL; Wong KF; Kho CS; Jin DY; Tse E; Rosèn A; Chim CS
J Transl Med; 2014 Feb; 12():52. PubMed ID: 24559316
[TBL] [Abstract][Full Text] [Related]
23. Promoter hypermethylation of Death-associated protein-kinase gene associated with advance stage gastric cancer.
Chan AW; Chan MW; Lee TL; Ng EK; Leung WK; Lau JY; Tong JH; Chan FK; To KF
Oncol Rep; 2005 May; 13(5):937-41. PubMed ID: 15809761
[TBL] [Abstract][Full Text] [Related]
24. Hypermethylation of death-associated protein (DAP) kinase CpG island is frequent not only in B-cell but also in T- and natural killer (NK)/T-cell malignancies.
Nakatsuka S; Takakuwa T; Tomita Y; Hoshida Y; Nishiu M; Yamaguchi M; Nishii K; Yang WI; Aozasa K
Cancer Sci; 2003 Jan; 94(1):87-91. PubMed ID: 12708480
[TBL] [Abstract][Full Text] [Related]
25. Epigenetic changes in the DAP-kinase CpG island in pediatric lymphoma.
Shiramizu B; Mick P
Med Pediatr Oncol; 2003 Dec; 41(6):527-31. PubMed ID: 14595709
[TBL] [Abstract][Full Text] [Related]
26. DAP-kinase hypermethylation in the bone marrow of patients with follicular lymphoma.
Voso MT; Gumiero D; D'Alo' F; Guidi F; Mansueto G; Di Febo AL; Massini G; Martini M; Larocca LM; Hohaus S; Leone G
Haematologica; 2006 Sep; 91(9):1252-6. PubMed ID: 16956827
[TBL] [Abstract][Full Text] [Related]
27. Frequent death-associated protein-kinase promoter hypermethylation in brain metastases of solid tumors.
Gonzalez-Gomez P; Bello MJ; Alonso ME; Lomas J; Arjona D; Amiñoso C; De Campos JM; Isla A; Gutierrez M; Rey JA
Oncol Rep; 2003; 10(4):1031-3. PubMed ID: 12792765
[TBL] [Abstract][Full Text] [Related]
28. Methylation of the APAF-1 and DAPK-1 promoter region correlates with progression of renal cell carcinoma in North Indian population.
Ahmad ST; Arjumand W; Seth A; Saini AK; Sultana S
Tumour Biol; 2012 Apr; 33(2):395-402. PubMed ID: 21922274
[TBL] [Abstract][Full Text] [Related]
29. Aberrant methylation of DAP-kinase in therapy-related acute myeloid leukemia and myelodysplastic syndromes.
Voso MT; Scardocci A; Guidi F; Zini G; Di Mario A; Pagano L; Hohaus S; Leone G
Blood; 2004 Jan; 103(2):698-700. PubMed ID: 14504087
[TBL] [Abstract][Full Text] [Related]
30. [Hypermethylation of DAP-kinase gene CpG Island in malignant lymphoma with B-cell phenotype].
Nakatsuka S; Takakuwa T; Aozasa K
Rinsho Byori; 2001 Dec; 49(12):1242-7. PubMed ID: 11797395
[TBL] [Abstract][Full Text] [Related]
31. High frequency of promoter hypermethylation of the death-associated protein-kinase gene in nasopharyngeal carcinoma and its detection in the peripheral blood of patients.
Wong TS; Chang HW; Tang KC; Wei WI; Kwong DL; Sham JS; Yuen AP; Kwong YL
Clin Cancer Res; 2002 Feb; 8(2):433-7. PubMed ID: 11839660
[TBL] [Abstract][Full Text] [Related]
32. Frequent death-associated protein kinase promoter hypermethylation in multiple myeloma.
Ng MH; To KW; Lo KW; Chan S; Tsang KS; Cheng SH; Ng HK
Clin Cancer Res; 2001 Jun; 7(6):1724-9. PubMed ID: 11410512
[TBL] [Abstract][Full Text] [Related]
33. Methylation of tumour suppressor genes APAF-1 and DAPK-1 and in vitro effects of demethylating agents in bladder and kidney cancer.
Christoph F; Kempkensteffen C; Weikert S; Köllermann J; Krause H; Miller K; Schostak M; Schrader M
Br J Cancer; 2006 Dec; 95(12):1701-7. PubMed ID: 17133271
[TBL] [Abstract][Full Text] [Related]
34. The association of death-associated protein kinase hypermethylation with early recurrence in superficial bladder cancers.
Tada Y; Wada M; Taguchi K; Mochida Y; Kinugawa N; Tsuneyoshi M; Naito S; Kuwano M
Cancer Res; 2002 Jul; 62(14):4048-53. PubMed ID: 12124340
[TBL] [Abstract][Full Text] [Related]
35. Tumor suppressor gene promoter hypermethylation in serum of breast cancer patients.
Dulaimi E; Hillinck J; Ibanez de Caceres I; Al-Saleem T; Cairns P
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6189-93. PubMed ID: 15448006
[TBL] [Abstract][Full Text] [Related]
36. Epigenetic silencing of tumor suppressor long non-coding RNA BM742401 in chronic lymphocytic leukemia.
Wang LQ; Wong KY; Li ZH; Chim CS
Oncotarget; 2016 Dec; 7(50):82400-82410. PubMed ID: 27689399
[TBL] [Abstract][Full Text] [Related]
37. Hypermethylation-mediated partial transcriptional silencing of DAP-kinase gene in bladder cancer.
Sobti RC; MalekZadeh K; Nikbakht M; Sadeghi IA; Shekari M; Singh SK
Biomarkers; 2010 Mar; 15(2):167-74. PubMed ID: 19958159
[TBL] [Abstract][Full Text] [Related]
38. Promoter methylation of DAP-kinase: association with advanced stage in non-small cell lung cancer.
Kim DH; Nelson HH; Wiencke JK; Christiani DC; Wain JC; Mark EJ; Kelsey KT
Oncogene; 2001 Mar; 20(14):1765-70. PubMed ID: 11313923
[TBL] [Abstract][Full Text] [Related]
39. Downregulation of death-associated protein kinase 1 (DAPK1) in chronic lymphocytic leukemia.
Raval A; Tanner SM; Byrd JC; Angerman EB; Perko JD; Chen SS; Hackanson B; Grever MR; Lucas DM; Matkovic JJ; Lin TS; Kipps TJ; Murray F; Weisenburger D; Sanger W; Lynch J; Watson P; Jansen M; Yoshinaga Y; Rosenquist R; de Jong PJ; Coggill P; Beck S; Lynch H; de la Chapelle A; Plass C
Cell; 2007 Jun; 129(5):879-90. PubMed ID: 17540169
[TBL] [Abstract][Full Text] [Related]
40. Hypermethylation of E-cadherin, p16, p14, and RASSF1A genes in pathologically normal urothelium predict bladder recurrence of bladder cancer after transurethral resection.
Lin HH; Ke HL; Wu WJ; Lee YH; Chang LL
Urol Oncol; 2012; 30(2):177-81. PubMed ID: 20800513
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
